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Abstract
A lattice gas model is proposed for investigating the release of drug molecules on devices with semi-permeable, porous
membranes in two and three dimensions. The kinetic of this model was obtained through the analytical solution of the
three-dimension diffusion equation for systems without membrane and with Monte Carlo simulations. Pharmaceutical
data from drug release is usually adjusted to the Weibull function, exp[−(t/τ)b], also known as stretched exponential,
and the dependence of adjusted parameters b and τ is usually associated, in the pharmaceutical literature, with physical
mechanisms dominating the drug dynamics inside the capsule. The relation of parameters τ and b with porosity λ are
found to satisfy, a simple linear relation for between τ and λ−1, which can be explained through simple physically based
arguments, and a scaling relation between b and λ, with the scaling coefficient proportional to the system dimension.
Keywords: drug release, Weibull distribution function, capsule membrane, porosity
1. Introduction
The advances in the synthesis technology of porous ma-
terials allowed the development of new matrices (mono-
lithic) and membrane pharmaceutical devices where size,
shape and pore distribution can be fine controlled during
the fabrication process [1, 2, 3, 4]. Understanding the con-
nection between drug release rates and the characteristics
of the device has an enormous potential for improving the
treatment of various diseases.
Mathematical modeling of drug release usually involves
finding the proper form of a diffusion equation consider-
ing the essential physical phenomena occurring as particles
diffuse through the capsule device [5, 6, 7]. In the phar-
maceutical literature it is also a common procedure to fit
drug release data to semi-empirical functions and use this
information to obtain insights onto the processes through
which the drug is released. Since many factors can con-
tribute to determine the final drug release, this procedure
can be subject to ambiguous interpretations that could
make the data analysis even more confusing [8]. Thus, a
more systematic approach for understanding the relation
between release data and physical processes occurring in-
side the capsule is desired. We work in this direction by
simulating minimalist lattice models devised to describe
both drug and physical device (or capsule) and investi-
gate the relation between drug release patterns and the
system porosity through the semi-empirical parameters of
the Weibull function.
Email addresses: aureliobarbosa@unb.br (Marco Aure´lio
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In this work a lattice gas model is proposed for inves-
tigating the release of drug molecules encapsulated on de-
vices with semi-permeable, porous membranes in two and
three dimensions, following a previous work on 1D and 2D
systems [9]. Release patterns were obtained through ana-
lytical solution of the three-dimension diffusion equation,
for systems without membrane, and Monte Carlo simula-
tions (MC), for systems with porous membrane, and ad-
justed to the Weilbull function, exp[−(t/τ)b], which is also
known as stretched exponential. The dependence of the
characteristic time τ with the membrane content, defined
as the inverse power of porosity, ζ = λ−1, was found to
satisfy linear relation, that is justified using reasonable
physical arguments. The parameter b was found to satisfy
a scaling relation with ζ from a regime without membrane
for up to 90% of membrane coverage.
This article is organized as follows, in the next section
we present the Weibull distribution and discuss previous
investigations about its semi-empirical parameters using
statistical mechanical models, the current model and the
simulations protocol are introduced in Section 2, while our
results and discussions are presented in Section 3. An an-
alytical solution for the diffusion equation of a continuous
system similar to our 3D lattice model is presented in Ap-
pendix A.
1.1. Weibull distribution
The Weibull distribution function was originally pro-
posed by Waloddi Weibull in 1951 as the ‘simplest possible’
empirical function that could be used to adjust non-linear
experimental data from complex systems [10]. Distribu-
tions on systems as diverse as electric bulb duration, life
Preprint submitted to Physica A October 22, 2019
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Figure 1: (Color online) Representation of a three-dimensional device with size L = 10 and porosity λ = 1/6 encapsulating drug molecules.
A few molecules (blue) are escaping through pores (yellow), while most particles are kept inside the capsule by the membrane covering it
(red). Release dynamics of a single simulation is illustrated in (b) while in (c) the same quantity is averaged over 250 different simulations.
expectancy in human populations, and yield strenght of
steel where well interpolated in the original work. For fur-
ther details on the Weibull distribution function see the
reference [11]. On the pharmaceutical research it was first
used to adjust data from drug release on 1972 by Langen-
bucher [12] and, since then, it became common to use the
Weibull function to obtain phenomenological insights into
the intrinsic mechanisms governing the drug release. As
discussed by Slater [13], it is appropriate to write this as:
N(t)
N0
= exp
[
−
(
t
τ
)b]
, (1)
where N(t) is the amount of drug molecules inside the
device as a function of time t and N0 ≡ N(0) is the
initial number of drug molecules inside the device. The
parameter τ is associated with the time where approxi-
mately 63% of the drug has been released and b with the
physical mechanisms leading to drug release within the de-
vice [12, 14, 15]. Expression 1 is also known as stretched
exponential, and b 6= 1 in diffusive models is usually as-
sociated to process with coloured noises and/or memory
effects [16, 17].
Lattice models have been used to investigate the rela-
tion between the release and capsule parameters [18, 19].
While early works were devoted to finding scaling proper-
ties of regular, fractal and multi-channel matrices [20, 21],
more recent work using lattice models (usually on the
pharmaceutical literature) was focused on validating the
usage of semi-empirical functions, as well as understand-
ing the relation between various physical aspects of the
capsule, such as shape, system dimension, drug concentra-
tion on drug release [22, 14, 23, 24, 25, 26, 15, 27, 28, 29,
30, 31, 32, 33, 9, 34, 35]. In the current work we inves-
tigate the relation between porosity and drug release by
using the Weibull function as an interpolating function, as
in the previously mentioned work, assuming that the semi-
empirical parameters b and τ retains relevant physical in-
formation about the nature of the capsule. We present
physical arguments which result in a linear relation be-
tween characteristic release times and membrane content
(which will be defined in terms of porosity, in the follow-
ing) and, besides that, results from Monte Carlo Simula-
tions indicate that the parameter b is related to porosity
through simple scaling relations.
2. Model and Monte Carlo Simulation
The model investigated here is based on a previous
work on 1D and 2D system inspired on the lattice gas
model to represent a system of device capsule plus drug,
and simulate the non-equilibrium drug release process [9].
The current modelling includes 2D square and 3D simple
cubic lattice, both with size L, for representing the devices
delivering drugs. Drug molecules are represented as single
particles occupying lattice sites and kinetics is obtained by
allowing particles to move randomly to unoccupied nearest
neighbor sites. Excluded volume interaction precludes two
drug molecules to share the same site. A membrane with
edge size L+1 covers the device and acts by blocking drug
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Figure 2: (a) For a cubic device without membrane, the Weibull function is fitted to release data from both the analytical solution of diffusion
equation (points) and Monte Carlo simulations with different sizes. In (b) the same data is shown in a triple log graph.
molecules from leaking to the outside environment. There
are n randomly positioned leaking sites on this membrane
“surface”, and the porosity parameter λ can be define as
λd = n/nS,d, where nS,d, the number of surface sites on
a capsule with dimension d, is identical to 4L (n/6L2) for
2D (3D) system. A single 3D model device with L = 10
(L3 = 103 sites) and porosity λ = 1/6 (100 leaking sites) is
represented on Fig. 1 (a). It is important to mention that
the current implementation of our simulation protocol fixes
the code of our previous 2D simulations [9] 1.
Drug release kinetics is obtained through Monte Carlo
simulations, as discussed in the literature [36, 37, 38], with
the difference that both the average and standard devia-
tion of particle numbers are collected on each time step.
On this work, standard deviations will be used to weight
data while adjusting the entire release curve to the Weibull
function. The reader is referred to the original work for
more details, but the main points of the MC simulation
protocol are described here for clarity. The initial config-
uration of all simulations is a filled device, i.e., the initial
number of particles is L2 (L3) on 2D (3D) and, on each de-
vice, its membrane leaking sites are randomly assigned in
accordance with its porosity value λ. On each simulation
drug particles are randomly selected and allowed to try a
random jump to a nearest neighbor site, and it is allowed
only if the new site is empty. After each attempted move-
ment time is incremented by a factor δt/N , where δt is a
standard MC time unit and N is the number of particles
remaining inside the capsule. Whenever a particle jumps
into a leaking site (pore) it is removed from the system,
thus decreasing the number of particles inside the capsule.
1The code used for generating the MC simulations in our previous
work [9] was written in C and presented a bias in the procedure for
sampling membrane pores, towards one of the edges. This error
introduced an artifact in the behavior of b as a function of λ, thus
hiding the scaling relations that we observed here for both 2D and
3D systems.
A number RL,λ of different simulations with the same size
and porosity run in parallel, each simulation ending when
at least 99.99% of the drug particles have leaked from the
capsule. After finishing all simulations release profiles are
obtained by calculating the average number of particles,
N(t), and standard deviation σ(t) =
√〈N(t)2〉 − 〈N(t)〉2
through the RL,λ simulations, with RL,λ numbers being
equal to 1000 and 250 in 2D and 3D systems, respectively.
A capsule with size L = 10 and a membrane with n =
100 leaking sites, corresponding to a porosity λ = 1/6, was
simulated to illustrate a typical model system, as shown
in Figs. 1(a)-(c). A single configuration is illustrated in
(a) while the output from a single simulation and the final
drug release profile, as averaged over 250 simulations, are
presented in Figs. 1 (b) and (c).
3. Results and discussion
We present results from MC simulations of devices in
two and three dimensions with edge sizes given by L2D ∈
{150, 200} and L3D ∈ {30, 40, 50}, respectively. The effect
of porosity was investigated by varying the parameter λ
from values corresponding to 1% to 100% of pores, with in-
crement steps of 1% 2. Once a release curve is obtained, as
illustrated in Fig.1 (c), the Weibull function is adjusted to
the data set and a scaling analysis is performed on the de-
pendence of the release parameters b and τ as a function of
the inverse porosity ζ = λ−1, which will be denominated as
membrane content hereafter3,4. A detailed investigation
2In both 2D and 3D models λ values were in the range between
0.01 to 1.00 with increments of 0.01.
3It should be possible to define the membrane content in various
ways. For instance, one could define it as the logarithm ζ = lnλ−1,
and even to normalize it by the maximum value. We decide to keep
it as simple as possible, resembling the observed scaling behavior.
4The membrane fraction is defined as λm = 1− λ and, for small
values it is related to the membrane content by:
ζ = 1/λ = 1/(1− λm) ≈ 1 + λm.
3
on 3D systems without membrane (i.e., ζ = 1) was done
by adjusting the Weibull equation to release data coming
from MC simulation and from the analytical solution of a
continuous system with similar boundary conditions and
will be discussed in the next subsection.
Before proceeding it should be important to note that
the standard deviation σ(t) is not commonly used or dis-
cussed in computer simulations of lattice models for drug
release[9, 22, 27]. In this work σ(t) was used as a data fluc-
tuation resembling the deviations observed in real systems,
resulting in an improved nonlinear fitting: in the case of a
3D capsule without membrane (ζ = 1) it was found that,
although it does not introduce any qualitative change on
the parameters b and τ its use allowed an improvement on
the fit to MC release data, as measured by the variance of
residuals 5.
3.1. Capsules without membrane
In the case of 3D devices without membrane (λ = 1) it
is possible to compare numerical simulations with the ana-
lytical solution to the diffusion equation, presented on Ap-
pendix A. On Fig. 2 release data from Eq. (A.6) and
results from simulations of devices with various sizes are
shown in parallel, with the Weibull function adjusted to
data from the analytical/continuous model. Variables are
normalized and drug release profiles are shown in (a) reg-
ular and (b) triple log 6 perspectives. As discussed pre-
viously [9], in the regular perspective Weibull functions
seems to accurately fit release data in the whole time in-
terval. Nevertheless, such analysis can be misleading and
a proper way to visually assess the quality of the fitting
procedure is to plot the data in a triple-log graph where
the Weibull function draws a straight line with slope b.
This point has as discussed by Langenbucher [12] and
others [40]. As depicted in Fig. 2 (b), the release data
slight deviates from the straight line on initial and final
release times, indicating that both regimes are not de-
scribed with precision by this empirical function. Igna-
cio and Slater noted that the Weibull function presents an
average compromise between the two limits and proposed
a new, physically compatible, semi-empirical function that
would be suited for adjusting those limiting conditions [40].
In Ref. [34] Christidi and Kalosakas have shown that sim-
ulation results deviates from Weibull mostly in the final
release, where the device loses its pharmaceutical usage,
thus justifying its usage on the context of lattice models
5The goodness of the fit can be measured by a value of variance
of residuals θ = χ2/ν, where χ are the residuals [39] and ν is the
difference between number of points and the number of parameters.
In the case of a 3D release capsule of size L = 40 without membrane
we observed that θ decreased by three orders of magnitude when
fitting the data with σ(t), with values 88.600 with σ and θ ≈ 121×103
without it.
6In the current context, a triple log corresponds to a double log-
arithm in the vertical axis and single logarithm in the horizantal
axis.
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Figure 3: (top) Phenomenological approach used to obtain the de-
pendence of the average residence time inside the capsule as a func-
tion of the porosity, Eq. (3). Bulk drug molecules spend a time τB to
leave the bulk, reaching the inner surface near to the membrane, and
a time τS to be released from the surface. (bottom) The normalized
characteristic time, (τ − τ∗B)/τ∗S , as a function of membrane content,
ζ = λ−1 (see text), for different capsule sizes in 2D and 3D lattice
models.
for drug release. A more detailed analysis on the data from
Fig. 2 allows us to infer that, in our model, MC data only
starts to significantly deviate from the adjusted Weibull
function after 95% of the capsule drug content has being
released, as observed before for another lattice model [34].
3.2. Phenomenological relation between τ and the mem-
brane content.
Now we will derive a phenomenological relation be-
tween a typical release and the porosity λ (or membrane
content, ζ = λ−1), which is illustrated on Fig. 3 (top).
For a large capsule only a small fraction of the particles
within it are located near the membrane and the aver-
age release time can be approximately described by the
average release time of a typical bulk particle. Without
considering reflection on the membrane any bulk particle
will spend an average time τB before reaching the interior
4
Model L τ∗B τ
∗
S τ
∗∗
B τ
∗∗
S η
2D 150 2195± 17 394± 1 2383± 5 309± 1 1.055(1)
200 4087± 20 533± 2 4315± 9 430± 3 1.049(1)
3D 40 134± 1 55.3± 0.1 120.6± 0.7 61.5± 0.3 0.975(1)
50 215± 2 69.3± 0.1 194.6± 0.9 79.2± 0.4 0.969(1)
Table 1: Parameters relating the characteristic Weibull time τ and membrane content, from expressions (3) and (4), fitted to drug release
data from model devices in two and three dimensions.
surface of the capsule, and an additional average time τS
to be released from the neighbourhood of the membrane to
the exterior medium. Since bulk sites are physically sep-
arated from the membrane pores by interior surface sites
it should be reasonable to think that τB is dependent on
the capsule size but not on the number membrane pores.
On the other hand, the average time that a given parti-
cle spends on a surface site near the membrane must be
a function of the number of pores. It is also expected a
divergence on the residence time τS in the case of a cap-
sule completely covered by a membrane, limλ→0 τS →∞,
and its value should decrease continuously by increasing
the number of pore sites, tending to a minimum value in
the case of a capsule without membrane (λ = 1). Thus,
it should be interesting to consider the latter function in
terms of membrane content, ζ = λ−1, and expand it as:
τS(ζ) = τS(0) + τ
′
S(0)ζ +O(ζ2). (2)
Using this expression on the Weibull parameter τ one ob-
tains:
τ ≈ τ∗B + τ∗S(0)ζ, (3)
where τ∗B = τB + τS(0) and τ
∗
S = τ
′
S(0).
Despite the simplicity of the arguments leading to ex-
pression (3), it reasonably reproduces the behavior of τ(ζ)
for 2D and 3D capsules under all porosity regimes, with
τ∗B and τ
∗
S as parameters adjusted from simulations, as
shown in Fig. 3 (bottom). The use of a second order ap-
proximation in (3) resulted in corrections three orders of
magnitude smaller than those of the first order contribu-
tion, indicating that eq. (3) is a reasonable approximation
to τ(ζ). Since the curves in this figure were almost linear,
we also considered the surface residence time scaling as a
power law of the membrane content, as
τ ≈ τ∗∗B + τ∗∗S (0)ζη, (4)
where η is a real coefficient. Table 1 lists the values of
parameters appearing on Eqs. (4) and (3) as well as those
used to investigate the behavior of b (discussed in the fol-
lowing subsection). It is interesting to stress that the val-
ues of η, which should be used as a scaling coefficient de-
scribing a scaling behavior connecting τ to ζ, eq. (4), is
close to identity, providing another validation for the phe-
nomenological derivation leading to eq. (3).
3.3. Scaling behavior of b with membrane content
In Figure 4 (a) we show the semi-empirical Weibull pa-
rameter b as a function of the membrane content ζ for 2D
(3D) capsules with sizes L = 150 and 200 (L = 40 and 50).
A single filled point (•) indicates the value b ≈ 0.65 ob-
tained from the solution of the diffusion equation without
membrane, whose diffusion profile is shown in Fig. 2. Note
that the same trend is observed in 2D and 3D: as a block-
ing membrane starts to cover the capsule b increases as a
power law from b(ζ = 1) ≈ 0.75 up to a point where 90%
capsule is covered with a membrane (at about λ−1 = 10)
and, after this region, b values start to increase in a less
pronounced way. In two dimensions, increments in b with
membrane content are slower but it still converges to an
uncorrelated exponential decay, with b ≈ 1, as found in
our previous work (see Ref. [9]). The same tendency is
observed regardless the sizes or dimensions. The behavior
of the Weibull parameter b for values of membrane content
ζ corresponding from no membrane (ζ = 1) to about 90%
of membrane coverage can be adjusted with the power law
expression:
b = b1ζ
µ, (5)
where b1 ≡ b(ζ = 1) is the size dependent contribution
to b, and µ is a scaling factor. In principle, the empirical
coefficient b does depend on size, porosity (or membrane
content) and system dimension. Since the contributions
coming from size and porosity were already taken account
on expression (5) through b1 and ζ, one could expect the
scaling coefficient µ to depend only on the system dimen-
sion, d. This hypothesis is supported by Fig. 4 (b), where
it is possible to infer that µ can be adjusted with a linear
relation of the type
µ ≈ a× d (6)
for capsules with less than 90% of membrane content, with
a ≈ 1/25. Note that Fig. 4 (b) confirms that a linear
relation for ln ζ ≈ ln(b/b1)1/d is approximately valid in
the interval 1 ≤ ζ < 10.
4. Conclusions
A simple lattice, statistical mechanical model based on
the lattice gas, has been proposed to investigate the de-
pendence of the drug release profile and porosity in 2D
and 3D models. The number of drug particles inside the
device was adjusted to the semi-empirical Weibull func-
tion, and a detailed investigation on the dependence of
the semi-empirical parameters b and τ with porosity (or
membrane content) was performed, based on Monte Carlo
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Figure 4: (a) Semi-empirical release parameter b against the membrane content. The point (•) denotes the value of b′ ≈ 0.65, obtained from
the solution to the diffusion of a device without membrane. (b) Log-log plot of the release parameter b normalized, [b/b1]1/d, as a function
of ζ, where d is the capsule dimensionality.
simulations. While a simple phenomenological argument
allowed us to write a linear relation between the charac-
teristic time τ and the membrane content, here defined as
ζ = 1/λ, numerical results allowed us to write b in terms
of a power law with a scaling exponent proportional to the
system dimension. Both results were validated using well
converged Monte Carlo simulations, where both the num-
ber of particles and its standard deviation across multiple
simulations were collected, with the latter being used as a
fluctuation whose usage significantly improved the fitting
to numerical data.
It should be interesting to note that our results cor-
roborates the classification of b values proposed by Pa-
padopoulou and et al. [15], which estimated that for b <
0.75 the release mechanism is mainly dominated by Fickian
diffusion, while diffusion is combined with another mech-
anism for values in the range 0.75 < b < 1.0 [15]. This
is in accordance with our results from Fig. 4 (a), since for
membrane content values corresponding to few membrane
sites, i.e., ζ → 1, we found b in the range 0.65−0.75, indi-
cating that random displacements, or Fickian diffusion, is
the principal mechanism for drug particles to release the
capsule. On the other hand, when the number of mem-
brane sites are increasing, and thus the escape probability
for particles inside the device are decreasing (high mem-
brane content values in the x−axis of Fig. 4 (a)), b values
are increasing in the range between 0.75 and 1.00. Again,
this is in agreement with the Papadopoulou et al. crite-
ria [15] since, in this regime, the heterogeneous membrane
becomes a major factor on limiting diffusion, thus blocking
drug particles from being released to the outside environ-
ment. Concomitant to the increase on b, observed with
the increase on membrane content.
We expect that our results can be useful for estimat-
ing release patterns in real drug carriers, such as porous
silicon nanoparticles, were porosity can be controlled by
fabrication and/or surface functionalization. It would be
possible, for instance, to use Eqs.(3) and (5) to extrapolate
the release profile of a small number of samples in order
to obtain the desired release profile, on monolitic devices
covered with porous membranes, thus reducing the num-
ber intermediate sample devices that should be prepared.
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Appendix A. Drug release from the solution of
the diffusion equation solution for
3D capsules without membrane
We use the diffusion equation to investigate a three-
dimensional cubic capsule of size L, with constant initial
drug load in analogy to our 3D lattice model without mem-
brane. By assuming that the diffusion coefficient D0 is
constant inside the capsule the Fick’s second law may be
written as [41, 42]:
∂C
∂t
= D0∇2C, (A.1)
where C ≡ C(x, t) is the drug concentration as a function
of the position x and the time t. The above equation is
subject to the initial condition and the boundary condi-
tion:
C(x, 0) = C0, (A.2)
C(0, t) = C(L, t) = 0, (A.3)
where C0 = N0/L
3 is the initial drug concentration and
N0 is the initial number of particles into the device.
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The equations (A.1), (A.2) and (A.3), can be solved by
standard variable separations and power series techniques.
By introducing reduced units:
x∗ = x/L, y∗ = y/L, z∗ = z/L,
t∗ = D0t/L2,
.C∗(x∗, y∗, z∗, t∗) =
C(x, y, z, t)
C30
,
(A.4)
the solution becomes:
C∗(x∗, y∗, z∗, t∗) =
64
pi3
∞∑
i,j,k=0
Cijk exp{−pi2t∗Aijk}
Bijk
(A.5)
where Aijk = [(2i + 1)
2 + (2j + 1)2 + (2k + 1)2], Bijk =
(2i+1)(2j+1)(2k+1) and Cijk = sin[(2i+1)pix
∗] sin[(2j+
1)piy∗] sin[(2k+1)piz∗]. The number of particles inside the
capsule can be calculated as:
N∗(t∗) =
∫ 1
0
dx∗
∫ 1
0
dy∗
∫ 1
0
dz∗C∗(x∗, y∗, z∗, t∗)
=
512
pi6
∞∑
i,j,k=0
exp{−pi2t∗Aijk}
B2ijk
.
(A.6)
For long time periods, t∗  3pi2, the release mechanism is
described by a single exponential decay:
N∗(t∗) ≈ 512
pi6
exp(−3pi2t∗). (A.7)
The average of the residence time in the capsule can
be obtained from (A.6) as
t∗ =
512
pi8
∞∑
i=0
∞∑
j=0
∞∑
k=0
1
Ai,j,kB2i,j,k
, (A.8)
The quantity t∗ ≈ 0.0185 can considered as a first ap-
proximation to the characteristic time τ on the Weibull
function.
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